blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2061779

EP2061779 - ARYL SULFONAMIDES WITH AN ANALGESIC ACTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.09.2014
Database last updated on 25.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MT  NL 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2013/45]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MT  NL 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2009/22]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MT  NL 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / KAUFFMANN-HEFNER, Iris
Oelbachstrasse 10/1
88448 Attenweiler / DE
02 / HAUEL, Norbert
Marderweg 12
88433 Schemmerhofen / DE
03 / WALTER, Rainer
Rudolfsgnadweg 5
88400 Biberach / DE
04 / EBEL, Heiner
Mondstr. 7
88400 Biberach / DE
05 / DOODS, Henri
Freiherr-von-Koenig-Str. 6
88447 Warthausen / DE
06 / CECI, Angelo
Obere Schügelestrasse 20
88441 Mittelbiberach / DE
07 / SCHULER-METZ, Annette
Holzgasse 7
89081 Ulm / DE
08 / KONETZKI, Ingo
Muellerweg 9
88447 Warthausen / DE
 [2009/22]
Representative(s)Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2012/40]
Former [2009/22]Hammann, Heinz, et al
Boehringer Ingelheim GmbH CD-Patents Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date07788420.314.08.2007
[2009/22]
WO2007EP58408
Priority number, dateDE2006103900319.08.2006         Original published format: DE102006039003
[2009/22]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2008022945
Date:28.02.2008
Language:DE
[2008/09]
Type: A1 Application with search report 
No.:EP2061779
Date:27.05.2009
Language:DE
The application published by WIPO in one of the EPO official languages on 28.02.2008 takes the place of the publication of the European patent application.
[2009/22]
Type: B1 Patent specification 
No.:EP2061779
Date:06.11.2013
Language:DE
[2013/45]
Search report(s)International search report - published on:EP28.02.2008
ClassificationIPC:C07D401/02, C07D311/16, C07D205/04, C07D207/06, C07D223/04, C07D403/04, C07D403/06
[2009/22]
CPC:
C07D401/02 (EP,KR,US); A61P25/00 (EP); A61P25/02 (EP);
A61P25/04 (EP); A61P25/06 (EP); A61P29/00 (EP);
C07C311/29 (EP,US); C07D205/04 (EP,US); C07D207/06 (EP,US);
C07D223/04 (EP,KR,US); C07D311/16 (KR); C07D403/04 (EP,KR,US);
C07D403/06 (EP,US); C07C2601/08 (EP,US); C07C2601/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/22]
Extension statesBA19.03.2009
HR19.03.2009
RS19.03.2009
TitleGerman:ARYLSULFONAMIDE MIT ANALGETISCHER WIRKUNG[2009/22]
English:ARYL SULFONAMIDES WITH AN ANALGESIC ACTION[2009/22]
French:ARYLSULFONAMIDES A EFFET ANALGESIQUE[2009/22]
Entry into regional phase19.03.2009National basic fee paid 
19.03.2009Designation fee(s) paid 
19.03.2009Examination fee paid 
Examination procedure19.03.2009Examination requested  [2009/22]
22.09.2009Despatch of a communication from the examining division (Time limit: M06)
11.03.2010Reply to a communication from the examining division
17.05.2010Despatch of a communication from the examining division (Time limit: M04)
11.09.2010Reply to a communication from the examining division
29.05.2013Communication of intention to grant the patent
26.09.2013Fee for grant paid
26.09.2013Fee for publishing/printing paid
Divisional application(s)EP10178252.2  / EP2284166
EP11176839.6  / EP2402329
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.09.2009
Opposition(s)07.08.2014No opposition filed within time limit [2014/42]
Fees paidRenewal fee
31.08.2009Renewal fee patent year 03
31.08.2010Renewal fee patent year 04
31.08.2011Renewal fee patent year 05
31.08.2012Renewal fee patent year 06
02.09.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.08.2007
BG06.11.2013
CY06.11.2013
CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
MC06.11.2013
MT06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
TR06.11.2013
GR07.02.2014
IS06.03.2014
PT06.03.2014
[2016/33]
Former [2016/32]HU14.08.2007
BG06.11.2013
CY06.11.2013
CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
MC06.11.2013
MT06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
GR07.02.2014
IS06.03.2014
PT06.03.2014
Former [2016/31]BG06.11.2013
CY06.11.2013
CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
MC06.11.2013
MT06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
GR07.02.2014
IS06.03.2014
PT06.03.2014
Former [2016/28]BG06.11.2013
CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
MC06.11.2013
MT06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
GR07.02.2014
IS06.03.2014
PT06.03.2014
Former [2016/25]BG06.11.2013
CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
MC06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
IS06.03.2014
PT06.03.2014
Former [2015/18]CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
MC06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
IS06.03.2014
PT06.03.2014
Former [2015/14]CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SI06.11.2013
SK06.11.2013
IS06.03.2014
PT06.03.2014
Former [2014/41]CZ06.11.2013
DK06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SK06.11.2013
IS06.03.2014
PT06.03.2014
Former [2014/38]CZ06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
IT06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SK06.11.2013
IS06.03.2014
PT06.03.2014
Former [2014/37]CZ06.11.2013
EE06.11.2013
ES06.11.2013
FI06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
PL06.11.2013
RO06.11.2013
SE06.11.2013
SK06.11.2013
IS06.03.2014
PT06.03.2014
Former [2014/36]EE06.11.2013
ES06.11.2013
FI06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
SE06.11.2013
IS06.03.2014
PT06.03.2014
Former [2014/28]ES06.11.2013
FI06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
SE06.11.2013
IS06.03.2014
PT06.03.2014
Former [2014/25]ES06.11.2013
FI06.11.2013
LT06.11.2013
LV06.11.2013
NL06.11.2013
SE06.11.2013
IS06.03.2014
Former [2014/24]ES06.11.2013
FI06.11.2013
LT06.11.2013
NL06.11.2013
SE06.11.2013
IS06.03.2014
Former [2014/23]FI06.11.2013
LT06.11.2013
NL06.11.2013
SE06.11.2013
IS06.03.2014
Former [2014/22]FI06.11.2013
LT06.11.2013
NL06.11.2013
SE06.11.2013
Former [2014/20]LT06.11.2013
Cited inInternational search[X]WO02053516  (FOURNIER LAB SA [FR], et al) [X] 1-4,8-11 * Formel I;; page 2, lines 1-5; examples 106,116; claims 1,10,11; table 3 *;
 [X]WO03106428  (FOURNIER LAB SA [FR], et al) [X] 1,5,6,8-11 * Formel I;; page 2, line 28 - page 3, line 2; examples 49,72; claims 1,10,11 *;
 [X]WO2006036664  (AMGEN INC [US], et al) [X] 1-11* Formel I;; paragraphs [0004] , [0334] - [0336]; examples 1-3,11,14-16,18,22,24; tables 1,2 *;
 [X]WO2006048209  (BOEHRINGER INGELHEIM INT [DE], et al) [X] 1,4-6,8-11 * Formel I; Verbindungen 17-24,28,36,38-40;; page 44, line 20 - page 45, line 28; examples 1-4,6,7,13,14,161-166; claims 1,3-5,7-9 *;
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 6007541, XP002466545 [X] 1-3,6 * column A *
    [ ] - EL-NAGGAR ET AL., POL. J. CHEM., (1982), vol. 56, no. 10-12, pages 1279 - 1285
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 6009473, XP002466834 [X] 1-3,6 * column A *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2905397, XP002466835 [X] 1-3,6 * column A *
    [ ] - BRAICHENKO, V. T., PHARM. CHEM. J. (ENGL. TRANSL.), (1972), vol. 6, no. 8, pages 492 - 494
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2400317, XP002466836 [X] 1-3,6 * column A *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 9271162, XP002466837 [X] 1-3,6 * column A *
    [ ] - MUKHERJEE, G. N., CHAKRABORTY, P. K., J. INDIAN CHEM. SOC., (2002), vol. 79, no. 2, pages 137 - 141
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 8906721, XP002466838 [X] 1-3,6 * column A *
    [ ] - SELVAMURUGAN, V., AIDHEN, INDRAPAL SINGH, SYNTHESIS, (2001), vol. 15, pages 2239 - 2246
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2709200, XP002466839 [X] 1-3,6 * column A *
    [ ] - PAUL, H. ET AL, ARCH. PHARM. BER. DTSCH. PHARM. GES., (1968), vol. 301, pages 512 - 519
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 8789325, XP002466840 [X] 1-3,6 * column A *
    [ ] - EL-SHARIEF, A. M. SH., AMMAR, Y. A., ZAHRAN, M. A., ALI, A. H., EL-GABY, M. S. A., MOLECULES, (2001), vol. 6, no. 3, pages 267 - 278
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2664221, XP002466841 [X] 1-3,6 * column A *
    [ ] - SHOEB ET AL., INDIAN J. CHEM., (1965), vol. 3, page 507
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2674860, XP002466842 [X] 1-3,6 * column A *
    [ ] - SEN, YAJNIK, J. INDIAN CHEM. SOC., (1965), vol. 42, pages 145 - 146
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2709563, XP002466843 [X] 1-3,6 * column A *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2709564, XP002466844 [X] 1-3,6 * column A *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2710222, XP002466845 [X] 1-3,6 * column A *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2956418, XP002466846 [X] 1-3,6 * column A *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Förderung der Wissenschaften, Frankfurt am Main, DE, Database accession no. BRN 2955989, XP002466847 [X] 1-3,6 * column A *
 [X]  - MOLANDER G A ET AL, "Reduction of 2-Acylaziridines by Samarium(II) Iodide. An Efficient and Regioselective Route to beta-Amino Carbonyl Compounds", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19970630), vol. 53, no. 26, ISSN 0040-4020, pages 8887 - 8912, XP004106098 [X] 1-3,6 * table 3 *
 [X]  - SARTORI E ET AL, "SYNTHESIS AND ACTIVITIES OF NET ARYLSULFONAMIDO THROMBOXANE A2 RECEPTOR ANTAGONISTS", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, (1993), vol. 28, no. 7/8, ISSN 0223-5234, pages 625 - 632, XP000396678 [X] 1-3,6 * examples VI-7,VI-8,VI-9; table 1 *

DOI:   http://dx.doi.org/10.1016/0223-5234(93)90093-T
by applicantDE1100635
 WO02053516
 WO03106428
 WO2006036664
 WO2006048209
    - HOUBEN-WEYL, METHODEN DER ORGANISCHEN CHEMIE, vol. 15/2
    - BIOORG. MED. CHEM. LETT., (2001), vol. 11, pages 2325 - 2330
    - J. MED. CHEM. SIR, (2005), vol. 48, no. 7, pages 2371 - 2387
    - J. MED. CHEM., (2004), vol. 47, pages 4300 - 4315
    - ACTA CHEM. SCAND. SER. B, (1988), vol. 42, pages 373 - 377
    - J. MED. CHEM., (1990), vol. 33, pages 1880 - 1887
    - TETRAHEDRON, (2001), vol. 57, pages 4781 - 4785
    - TETRAHEDRON, (1991), vol. 47, pages 3969 - 3980
    - TETRAHEDRON, (1999), vol. 55, pages 13285 - 13300
    - CHEM. PHARM. BULL., (1997), vol. 45, pages 996 - 1007
    - J. MED.CHEM., (2003), vol. 46, pages 4952 - 4964
    - CHEM. PHARM. BULL., (1994), vol. 42, pages 74 - 84
    - J. MED. CHEM., (1993), vol. 36, pages 162 - 165
    - PHARM. ACTA HELV., (1969), vol. 44, pages 637 - 643
    - J. ORG. CHEM., (1968), vol. 33, pages 3637 - 3639
    - J. AM. CHEM. SOC., (1971), vol. 93, pages 4256 - 4263
    - J. MED. CHEM., (1998), vol. 41, pages 5219 - 5246
    - J. MED. CHEM., (1998), vol. 41, pages 4317 - 4328
    - J. MED. CHEM., (1985), vol. 28, pages 1533 - 1536
    - J. CHEM. SOC., (1935), page 871
    - EUR. J. MED.CHEM. CHIM. THER., (2002), vol. 37, pages 487 - 502
    - CHEM. PHARM BULL., (1997), vol. 45, pages 1458 - 1469
    - J. MED. CHEM., (2003), vol. 46, pages 5445 - 5457
    - J. MED. CHEM., (1983), vol. 26, pages 309 - 312
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.